Skip to main content
NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+2.59%GOOGL+0.45%MSFT-0.04%AMZN-0.07%TSM-1.20%SPCX+1.15%AVGO-0.54%META-0.77%TSLA-0.64%SKHY-3.86%MU-4.52%BRK-B-0.16%LLY+0.40%JPM-0.53%WMT+0.12%AMD-2.80%V-0.31%XOM+0.85%ASMLa-1.66%JNJ+0.01%INTC-4.89%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.73%ABBV+0.69%BAC-0.47%CSCO-1.32%CVX-0.09%COST-0.15%KO+0.66%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.47%UNH-0.55%HSBA.L-1.30%DELL-3.92%PG+0.14%MS-0.99%GE-0.74%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.02%HD-1.60%0939.HK+1.66%GS-1.00%NZDJPY-2.57%AUDJPY-1.80%CHFJPY-1.58%NZDCAD-1.44%EURNZD+1.42%NZDUSD-1.38%GBPNZD+1.37%USDJPY-1.22%GBPJPY-1.21%EURJPY-1.20%CADJPY-1.15%NZDCHF-1.03%USDZAR+1.02%USDSEK+0.88%EURZAR+0.87%USDNOK+0.86%AUDNZD+0.80%GBPZAR+0.79%EURSEK+0.73%EURNOK+0.72%AUDCAD-0.68%AUDDKK-0.64%EURAUD+0.61%USDTHB+0.60%AUDUSD-0.58%GBPAUD+0.57%CHFSEK+0.57%CHFNOK+0.55%AUDSGD-0.53%USDMXN+0.44%CADCHF+0.42%USDPLN+0.41%GBPTRY+0.41%NZDSGD-0.40%EURCHF+0.38%USDCHF+0.37%GBPCHF+0.35%NOKJPY-0.34%GBPHKD+0.32%GBPMXN-0.28%SGDJPY+0.26%EURPLN+0.26%USDSGD+0.25%NZDMXN-0.23%AUDCHF-0.22%USDILS+0.16%EURHKD-0.16%USDDKK+0.15%USDTRY+0.11%PLNJPY+0.11%EURSGD+0.11%USDCNH+0.10%EURCZK-0.09%GBPCAD-0.08%AUDNOK+0.07%USDCAD-0.06%CHFSGD-0.06%EURCAD-0.05%USDCOP-0.04%EURGBP+0.03%EURCNH-0.03%GBPSGD+0.02%EURUSD+0.02%USDHKD+0.01%GBPUSD+0.01%EURDKK0.00%XPTUSD-5.82%UKOIL+5.74%USOIL+5.51%GAGUSD-5.16%XAGUSD-5.16%HG1-4.93%GAUUSD-1.33%XAUUSD-1.33%XNGUSD+1.26%S1+0.97%COTTON+0.95%W1+0.92%BTCUSD-1.60%ETHUSD-0.41%USDTUSD-0.03%XRPUSD-3.15%SOLUSD-2.06%TRXUSDT+0.18%ZECUSDT-8.90%DOGEUSD-3.20%XMRUSDT-0.36%LINKUSD-1.58%XLMUSD-1.64%BCHUSDT-10.50%LTCUSD-2.09%UNIUSD-2.09%TONUSD+24.88%HBARUSDT-2.57%SUIUSD-4.44%TAOUSDT-5.35%AAVEUSD-2.69%DOTUSDT-2.18%ICPUSDT-2.12%ONDOUSDT-3.45%WLDUSDT-3.15%ATOMUSDT-3.73%ARBUSDT-0.36%JUPUSDT-4.67%INJUSDT-3.45%STXUSDT-3.80%FETUSDT-3.74%TIAUSDT-1.39%PYTHUSDT-1.39%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.69%WIFUSDT-5.87%OPUSDT-4.00%POLUSDT-4.55%IOTAUSDT-4.04%AXSUSDT-2.68%FARTCOINUSDT-4.54%EOSUSDT-3.15%DYDXUSDT-2.64%ORDIUSDT-1.16%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
AB

Aura Biosciences, Inc. (AURA)

NASDAQ • Healthcare

$7.2
-$0.16 (-2.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$7.34
Previous Close$7.2
Day Range$7.16 - $7.39
Avg. Volume (3M)839.1K
Market Cap$720.2M
52 Week Range
$4.73$9.54
Next EarningsIn 63 daysNov 12, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$131M
EPS (TTM)
-$1.78
ROA (TTM)
-37.63%
Current Ratio
16.82

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+14.0%Q1 2026-$0.37
-25.0%Q2 2026-$0.5
-28.0%Q3 2026-$0.48
Next

Nov 12

in 63 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Aura Biosciences, Inc.

Aura Biosciences, Inc. is a NASDAQ-listed biotechnology company in the healthcare sector that develops cancer treatments. It is a small-cap drug developer centered on ocular and urologic oncology, with its lead program AU-011 in development for primary choroidal melanoma and built on a proprietary virus-like drug conjugate platform.

Name
Aura Biosciences, Inc.
CEO
Natalie C. Holles
Website
www.aurabiosciences.com
Industry
Healthcare
Year Founded
2009
Employees
113

Today's Snapshot

AI-generated

AURA is trading 3.3% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (514.7K)

330.9K

vs S&P 500 Today

Underperforming Market

-2.76%

Updated: September 10, 2026 at 16:58 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
AURA shows short-to-medium weakness as price sits under most short-term moving averages while remaining just above long-term 200-day levels, suggesting longer-run support but near-term pressure. Momentum measures are soft, with RSI below neutral and CCI notably negative, while MACD is marginally negative, which together point to fading upside conviction. Trend strength is muted, with a low ADX, and volume-based OBV is negative, implying distribution rather than accumulation. Volatility is moderate given the ATR. Technical takeaway: Sell — short-to-medium term weakness dominates despite long-term support.
All signals
  • EMA (5 indicators)$6.71 - $7.45
    Sell
  • RSI (14)39.46
    Neutral
  • Stochastic %K (14, 3, 3)15.58
    Buy
  • MACD Level (12, 26)-0.05
    Sell

Peers & Related Assets

DSGNDesign Therapeutics, Inc.
$15.02-1.4%
SLDBSolid Biosciences Inc.
$9.54-3.9%
ANNXAnnexon, Inc.
$4.37-6.4%
ALTAltimmune, Inc.
$3.35-0.3%
RCKTRocket Pharmaceuticals, Inc.
$3.63-2.2%
QSIQuantum-Si incorporated
$0.75-1.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.